North Dakota Administrative Code › Title 33 - State Department of Health › Article 33-44 - Medical Marijuana › Chapter 33-44-01 - Medical Marijuana › Section 33-44-01-01 - Definitions

Current through Supplement No. 393, July, 2024
In this chapter, unless the context otherwise
				  requires:
1. "Activation time" means
				the amount of time it is likely to take for an individual to begin to feel the
				effects of ingesting or inhaling usable marijuana.
2. "Adverse reaction" means an unwanted,
				unexpected, or dangerous effect caused by the administration of usable
				marijuana dispensed pursuant to North Dakota Century Code chapter
				19-24.1.
3. "Analyte" means a
				component, substance, or chemical or microbiological constituent that is of
				interest in an analytical procedure or test.
4. "Batch" means a quantity of dried leaves
				and flowers from a harvest lot, a quantity of cannabinoid concentrate, or
				medical cannabinoid product from a process lot.
5. "Compliance test" means a test required by
				these rules to be performed by a laboratory selected by the department in order
				to allow the transfer or sale of usable marijuana.
6. "Container" means a sealed, hard- or
				soft-bodied receptacle in which usable marijuana is placed.
7. "Container identification number" means
				the identification number that was generated by the manufacturing facility at
				the time the usable marijuana was packaged and labeled for sale to the
				dispensary.
8. "Cotyledons" means
				an embryonic leaf of a plant, one or more of which are the first leaves to
				appear.
9. "Date of harvest" means
				the date the mature marijuana plants in a harvest lot were removed from the
				soil or other growing media. If the harvest occurred on more than one day, the
				"date of harvest" is the day the last mature marijuana plant in the harvest lot
				was removed from the soil or other growing media.
10. "Degradation compound" or "Pesticide
				degradate" means a resultant product from the transformation of a parent
				compound to a product with different physical and chemical properties, the fate
				and significance of which, is altered due to the structural changes.
11. "Harvest lot" means a specifically
				identified quantity of the same strain of marijuana that is cultivated
				utilizing the same growing practices, harvested within a seventy-two-hour
				period at the same location, and cured under uniform conditions.
12. "Hazardous waste" means the same as
				defined in North Dakota Century Code chapter 23-20.3.
13. "Laboratory" means a laboratory selected
				by the department in accordance with section
				33-44-01-36
				to sample and conduct tests in accordance with these rules.
14. "Medical marijuana waste" means the same
				as defined in North Dakota Century Code chapter 19-24.1.
15. "Net weight" means the gross weight minus
				the tare weight of the packaging.
16. "Parent compound" means the original
				molecular structure from which other compounds can be derived through a
				chemical reaction or natural breakdown process.
17. "Pediatric symbol" means the image,
				established by the department and made available to manufacturing facilities,
				indicating the product complies with the pediatric medical marijuana maximum
				concentration limit as defined in North Dakota Century Code chapter
				19-24.1.
18. "Plant" means a
				marijuana plant that has produced cotyledons or a cutting of a marijuana plant
				that has produced cotyledons.
19.
				"Process lot" means any amount of:
a.
				Cannabinoid concentrate of the same type and processed within a
				forty-eight-hour period, unless prior written authorization is received from
				the department, using the same extraction methods, standard operating
				procedures, and batches, not to exceed three, of the same strain from the same
				or a different harvest lot; or
b.
				Medical cannabinoid product of the same type and processed within a
				forty-eight-hour period, unless prior written authorization is received from
				the department, using the same ingredients, standard operating procedures, and
				a process lot or process lots, not to exceed three, of cannabinoid concentrate
				as defined in subsection a.